"The Taconic Knockout Repository eliminates the time traditionally required for model design and development, which can speed drug development for investigators in the region," Mr Little said. The agreement gives the Indian pharmaceutical and biotech research community access to Taconic's advanced scientific services, including model derivation, cryopreservation, genotyping, health assessment, and custom model generation.

All local breeding will be done at Vivo Bio Tech's 125,000-square-foot pre-clinical research facility in Andhra Pradesh, India. The facility is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care and registered with Committee for the Purpose of Control and Supervision of Experiments on Animals for breeding and commercialization of Murine Pathogen Free (MPF) animals. Throughout the breeding process, Vivo Bio Tech's highly qualified and well-trained staff will follow Taconic's rigorous standard operating procedures to ensure quality and integrity.